Peters CJ - Search Results

1

The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses.

Xu W, Watts DM, Costanzo MC, Tang X, Venegas LA, Jiao F, Sette A, Sidney J, Sewell AK, Wooldridge L, Makino S, Morrill JC, Peters CJ, Kan-Mitchell J. Xu W, et al. Among authors: peters cj. PLoS One. 2013;8(3):e59210. doi: 10.1371/journal.pone.0059210. Epub 2013 Mar 18. PLoS One. 2013. PMID: 23527138 Free PMC article.

2

Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA.

Morrill JC, Ikegami T, Yoshikawa-Iwata N, Lokugamage N, Won S, Terasaki K, Zamoto-Niikura A, Peters CJ, Makino S. Morrill JC, et al. Among authors: peters cj. PLoS One. 2010 Apr 1;5(4):e9986. doi: 10.1371/journal.pone.0009986. PLoS One. 2010. PMID: 20376320 Free PMC article.

3

Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.

Morrill JC, Peters CJ. Morrill JC, et al. Among authors: peters cj. J Infect Dis. 2011 Jul 15;204(2):229-36. doi: 10.1093/infdis/jir249. J Infect Dis. 2011. PMID: 21673033

4

Mapping a Major Gene for Resistance to Rift Valley Fever Virus in Laboratory Rats.

Busch CM, Callicott RJ, Peters CJ, Morrill JC, Womack JE. Busch CM, et al. Among authors: peters cj. J Hered. 2015 Nov-Dec;106(6):728-33. doi: 10.1093/jhered/esv087. Epub 2015 Nov 6. J Hered. 2015. PMID: 26546799

5

Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.

Pittman PR, Norris SL, Brown ES, Ranadive MV, Schibly BA, Bettinger GE, Lokugamage N, Korman L, Morrill JC, Peters CJ. Pittman PR, et al. Among authors: peters cj. Vaccine. 2016 Jan 20;34(4):523-530. doi: 10.1016/j.vaccine.2015.11.078. Epub 2015 Dec 17. Vaccine. 2016. PMID: 26706271 Free PMC article. Clinical Trial.

6

Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease.

Watts DM, Westover JLB, Palermo PM, Bailey KW, Morrill JC, Bettinger GE, Monath TP, Smith DR, Peters CJ, Pittman PR, Orbegozo J, Gowen BB. Watts DM, et al. Among authors: peters cj. Am J Trop Med Hyg. 2022 Sep 19;107(5):1091-1098. doi: 10.4269/ajtmh.22-0356. Print 2022 Nov 14. Am J Trop Med Hyg. 2022. PMID: 36122681 Free PMC article.

7

Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system.

Ikegami T, Peters CJ, Makino S. Ikegami T, et al. Among authors: peters cj. J Virol. 2005 May;79(9):5606-15. doi: 10.1128/JVI.79.9.5606-5615.2005. J Virol. 2005. PMID: 15827175 Free PMC article.

8

Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment.

Ikegami T, Won S, Peters CJ, Makino S. Ikegami T, et al. Among authors: peters cj. J Virol. 2005 Sep;79(18):12106-11. doi: 10.1128/JVI.79.18.12106-12111.2005. J Virol. 2005. PMID: 16140788 Free PMC article.

9

Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.

Ikegami T, Won S, Peters CJ, Makino S. Ikegami T, et al. Among authors: peters cj. J Virol. 2006 Mar;80(6):2933-40. doi: 10.1128/JVI.80.6.2933-2940.2006. J Virol. 2006. PMID: 16501102 Free PMC article.

10

NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture.

Won S, Ikegami T, Peters CJ, Makino S. Won S, et al. Among authors: peters cj. J Virol. 2006 Aug;80(16):8274-8. doi: 10.1128/JVI.00476-06. J Virol. 2006. PMID: 16873285 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

531 results

Search Page